Lucid-MS Restores Motor Function in Mouse Model, Company Says

Lucid-MS Restores Motor Function in Mouse Model, Company Says

313436

Lucid-MS Restores Motor Function in Mouse Model, Company Says

Lucid-MS, a new chemical molecule being developed by FSD Pharma for the treatment of multiple sclerosis (MS), has shown the ability to restore motor function in an animal model of the disease, the company announced. After about 50 days of treatment, animals receiving Lucid-MS showed a marked decrease in clinical severity scores, and their motor function was similar to that of healthy mice. The company is now preparing to submit an investigational new drug application…

You must be logged in to read/download the full post.